New Bispecific Antibody Approved for Tough-to-Treat Lymphoma
The FDA has granted accelerated approval to glofitamab (Columvi) for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), ...
Read moreDetailsThe FDA has granted accelerated approval to glofitamab (Columvi) for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), ...
Read moreDetailsJune 17, 2023 We encourage organizations to republish our content, free of charge. Here’s what we ask: You must credit ...
Read moreDetailsNorwegian officials are investigating an E. coli outbreak that has affected half a dozen people. The Norwegian Institute of Public ...
Read moreDetailsPerhaps not as far as I would have gone – “Get the F out of the FDA” – but a ...
Read moreDetailsThe Colorado Department of Public Health and Environment is currently investigating an outbreak from the microscopic parasite Cyclospora. As of ...
Read moreDetailsThe Association of Food and Drug Officials (AFDO) has introduced a Food Safety Regulatory Professional Credentialing program. The program is ...
Read moreDetailsBy: The Associated Press Posted: 7:14 AM CDT Sunday, Jun. 18, 2023 TUNIS, Tunisia (AP) — Ministers from Germany and ...
Read moreDetailsLOS ANGELES (AP) — You could call her the mother of Father’s Day. The late Sonora Smart Dodd launched the ...
Read moreDetailsBy: Tia Goldenberg, The Associated Press Posted: 6:58 AM CDT Sunday, Jun. 18, 2023 Last Modified: 7:30 AM CDT Sunday, ...
Read moreDetailsBy: Graham Dunbar, The Associated Press Posted: 6:52 AM CDT Sunday, Jun. 18, 2023 GENEVA (AP) — A project using ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info